• Deidentified data from the Lower Tidal Volume (ARMA) trial available on NHLBI website link

• May 2008: The public data release for the Fluid and Catheter Treatment trial (FACTT) and Late Phase Steriod use (LaSRS) is now available on NHLBI website link.

Data and Sample Request Information

Requests relating to open period studies

All requests for data and/or samples from open period studies must go through the NHLBI. Please contact biorepository@nhlbi.nih.gov or Elizabeth Wagner, the NHLBI Repository Project Office wagnere@nhlbi.nih.gov.

The following studies are considered open period studies:

• ARMA/KARMA/LARMA (ARDSNet 01 and 03)
• ALVEOLI (ARDSNet 04)
• FACTT (ARDSNet 05)

Summary of required steps for submitting a proposal that includes biologic materials relating to proprietary period studies (ALTA and EDEN-Omega):

1. Follow the application submission instructions for proposals listed in the Sub-study and Ancillary Study Process (updated Jan 2008) document.
2. Once you have received approval from the Pathogenesis Committee, submit a request for samples to the NHLBI Repository Project Officer, Liz Wagner (wagnere@nhlbi.nih.gov) using the specified process listed in item 4 (Note: proposals using only DNA samples do NOT require this step).
3. You will need to include the Pathogenesis Committee approval letter from Dr. Hubmayr with your submission.
4. Please follow the instructions detailed in the NHLBI Biologic Specimen Repository Accessioning Request Checklist (not required for DNA only proposals).
5. You will receive notification from Ms. Wagner regarding approval of your request for samples. Once you receive this notification, please use the ARDSNet Sample and Data Request Form to request samples and/or data. Your request will be received by the CCC who will assist you with aquiring samples from the SeraCare Biorepository as well as putting you together with a CCC statistican.
6. Please direct questions to Rolf Hubmayr, Chair or Nancy Ringwood at the CCC.